Arthur M. Bruskin
Nessuna posizione attualmente
Profilo
Arthur M.
Bruskin served as the Chief Scientific Officer at Interpath Pharmaceuticals, Inc. from 2005 to 2006.
He then worked as the Chief Operating Officer at Eutropics Pharmaceuticals, Inc. from 2006 to 2008.
From 2008 to 2012, he was an Independent Director at Arbutus Biopharma Corp.
and also served as the Executive Vice President-Global Research at OSI Pharmaceuticals, Inc. Dr. Bruskin holds a doctorate degree from Indiana University and undergraduate and graduate degrees from the University of Connecticut.
Precedenti posizioni note di Arthur M. Bruskin
Società | Posizione | Fine |
---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Direttore/Membro del Consiglio | 01/06/2012 |
Eutropics Pharmaceuticals, Inc.
Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Direttore operativo | 01/01/2008 |
Interpath Pharmaceuticals, Inc.
Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2002 |
Formazione di Arthur M. Bruskin
University of Connecticut | Graduate Degree |
Indiana University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Aziende private | 3 |
---|---|
Eutropics Pharmaceuticals, Inc.
Eutropics Pharmaceuticals, Inc. Internet Software/ServicesTechnology Services Eutropics Pharmaceuticals, Inc. operates as a biomarker technology platform for accelerating drug discovery and development. The private company is based in Cambridge, MA. The company was founded in 2005 by Gary E. Frashier, Michael Cardone. Michael Cardone has been the CEO since 2005. | Technology Services |
Interpath Pharmaceuticals, Inc.
Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Interpath Pharmaceuticals, Inc. develops cancer therapeutics based on liposomal delivery technology for antisense. The company was founded in 2001 by Gabriel Lopez-Berestein and Peter Nielsen and is headquartered in Houston, TX | Health Technology |
OSI Pharmaceuticals, Inc.
OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
- Borsa valori
- Insiders
- Arthur M. Bruskin